Medical Devices Investors & VC Firms in United Kingdom

104 firms in this list, with a median first check of $540K. 3 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
SV SV Health Investors ARASBFGM17 people · Leads rounds	88🔒	Boston	US	Pre-Seed–Late Stage	$1M – $20M	+ Add to CRM
BA Basecamp Fund BOJGLAMC13 people · Follows rounds	88🔒	Manchester	US	Pre-Seed–Late Stage	$100K – $10M	+ Add to CRM
AD Advent Life Sciences FMDSSJGJ25 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
NO Novo Holdings KKBFHBKS35 people	88🔒	Copenhagen	DK	Pre-Seed–Late Stage	$1.1M – $54M	+ Add to CRM
SY Syncona CHHGKBMP33 people	88🔒	London	GB	Pre-Seed–Late Stage	—	+ Add to CRM
AP Apple Tree Venture Management Llc SHABJWSL20 people	88🔒	New York	US	Pre-Seed–Late Stage	—	+ Add to CRM
36 360 Capital AZAMCMCC11 people	88🔒	Paris	FR	Pre-Seed–Series B	$162K – $10.8M	+ Add to CRM
AN Angel Academe STSHYMAM14 people · Follows rounds	88🔒	London	GB	Seed–Series A	$11K – $385K	+ Add to CRM
EP Epidarex Capital ASERKSLG9 people · Leads rounds	88🔒	Bethesda	US	Pre-Seed–Series A	$2.5M – $6.3M	+ Add to CRM
4B 4BIO Capital AKDKDKKM26 people	88🔒	London	GB	Pre-Seed–Series B	—	+ Add to CRM
DE Delin Ventures ILCFCSID21 people	88🔒	London	GB	Pre-Seed–Series A	$216K – $2.2M	+ Add to CRM
NS NSV AABMSSTL7 people · Leads rounds	88🔒	Greenwich	US	Seed–Late Stage	$2M – $8M	+ Add to CRM
SA Samsung Ventures DSJKJWMP22 people	88🔒	Menlo Park	US	Seed–Late Stage	—	+ Add to CRM
HE Heran Partners KVMTRRGD12 people	88🔒	Antwerp	BE	Seed–Series B	—	+ Add to CRM
CL Clarendon Fund Managers Ltd. BCCOJCMW11 people	88🔒	Belfast	GB	Seed–Series A	$317.5K – $3.8M	+ Add to CRM
EQ EQT Life Sciences APFVFAJR11 people	88🔒	Amsterdam	NL	Series A–Late Stage	$10.8M – $64.8M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
HE Hercules Capital, Inc. BJCJGPJB11 people	88🔒	San Mateo	US	Seed–Late Stage	$500K – $50M	+ Add to CRM
JJ JJDC FMHPLTTM11 people	88🔒	New Brunswick	US	Seed–Series B	$500K – $5M	+ Add to CRM
KO Korys DCBDDLDD11 people	88🔒	Halle	BE	Growth	$5.4M	+ Add to CRM
LD LDC AUCHDADA11 people	88🔒	London	GB	Growth	$12.7M – $127M	+ Add to CRM
MV MVM Life Science Partners APEBEFHH11 people	88🔒	Boston	US	Seed–Late Stage	$3.8M	+ Add to CRM
NO Norrsken VC NAAFADDF11 people	88🔒	Stockholm	SE	Seed–Series A	$1.1M – $3.2M	+ Add to CRM
UK UKSE SHMSHTML11 people	88🔒	Sheffield	GB	Series A–Late Stage	$31.8K – $1.3M	+ Add to CRM

SV Health Investors

BostonPre-Seed–Late Stage$1M – $20M

ARASBFGM17 people

Basecamp Fund

ManchesterPre-Seed–Late Stage$100K – $10M

BOJGLAMC13 people

Advent Life Sciences

LondonSeed–Late Stage

FMDSSJGJ25 people

Novo Holdings

CopenhagenPre-Seed–Late Stage$1.1M – $54M

KKBFHBKS35 people

Syncona

LondonPre-Seed–Late Stage

CHHGKBMP33 people

Apple Tree Venture Management Llc

New YorkPre-Seed–Late Stage

SHABJWSL20 people

360 Capital

ParisPre-Seed–Series B$162K – $10.8M

AZAMCMCC11 people

Angel Academe

LondonSeed–Series A$11K – $385K

STSHYMAM14 people

Epidarex Capital

BethesdaPre-Seed–Series A$2.5M – $6.3M

ASERKSLG9 people

4BIO Capital

LondonPre-Seed–Series B

AKDKDKKM26 people

Delin Ventures

LondonPre-Seed–Series A$216K – $2.2M

ILCFCSID21 people

NSV

GreenwichSeed–Late Stage$2M – $8M

AABMSSTL7 people

Samsung Ventures

Menlo ParkSeed–Late Stage

DSJKJWMP22 people

Heran Partners

AntwerpSeed–Series B

KVMTRRGD12 people

Clarendon Fund Managers Ltd.

BelfastSeed–Series A$317.5K – $3.8M

BCCOJCMW11 people

EQT Life Sciences

AmsterdamSeries A–Late Stage$10.8M – $64.8M

APFVFAJR11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Hercules Capital, Inc.

San MateoSeed–Late Stage$500K – $50M

BJCJGPJB11 people

JJDC

New BrunswickSeed–Series B$500K – $5M

FMHPLTTM11 people

Korys

HalleGrowth$5.4M

DCBDDLDD11 people

LDC

LondonGrowth$12.7M – $127M

AUCHDADA11 people

MVM Life Science Partners

BostonSeed–Late Stage$3.8M

APEBEFHH11 people

Norrsken VC

StockholmSeed–Series A$1.1M – $3.2M

NAAFADDF11 people

UKSE

SheffieldSeries A–Late Stage$31.8K – $1.3M

SHMSHTML11 people

Data sourced from public filings and firms' own websites — see our methodology.